Hypolipidemic agents
Attualità nellimpiego delle statine Prof. P. Pauletto Dip. di Medicina Clinica e Sperimentale Università degli Studi di Padova U.O. di Medicina Interna.
Dislipidemia Fluvas ok.ppt
Dy Spide Miafd
LEO ATP IV ppt
Statins and CAD Prevention: Rosuvastatin. Rising burden of CVD in India (2005) Lancet 2005;366:1744-9 Estimated proportions of total deaths and DALYs.
Presenter Disclosure Information Paul M Ridker, MD, FACC Dr Ridker is listed as a co-inventor on patents held by the Brigham and Women’s Hospital that.
Efficacy of statins in primary and secondary prevention of CV events - well established Meta-analyses of RCTs : - demonstrated dramatic reductions in.
Lipids: Is Lower Better For Diabetic Patients? Prof. Samir Helmy Assaad -Khalil Department of Internal Medicine Unit of Diabetes, Lipidology & Metabolism.
Reference: Circulation Journal 2009; 73(11): 2110-2117 Circulation journal : official journal of the Japanese Circulation Society AZT-CRES-10007 Jan-2010.
VOYAGER An indiVidual patient data meta- analysis Of statin therapY in At risk Groups: Effects of Rosuvastatin, atorvastatin and simvastatin Please see.
Flow of study participants
